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Background: Hematopoietic stem cells (HSCs) are a rare cell type with the ability of long-term self-renewal and
multipotency to reconstitute all blood lineages. HSCs are typically purified from the bone marrow using cell surface
markers. Recent studies have identified significant cellular heterogeneities in the HSC compartment with subsets of
HSCs displaying lineage bias. We previously discovered that the transcription factor Bcl11a has critical functions in
the lymphoid development of the HSC compartment.
Results: In this report, we employ single-cell transcriptomic analysis to dissect the molecular heterogeneities in
HSCs. We profile the transcriptomes of 180 highly purified HSCs (Bcl11a+/+ and Bcl11a−/−). Detailed analysis of the
RNA-seq data identifies cell cycle activity as the major source of transcriptomic variation in the HSC compartment,
which allows reconstruction of HSC cell cycle progression in silico. Single-cell RNA-seq profiling of Bcl11a−/− HSCs
reveals abnormal proliferative phenotypes. Analysis of lineage gene expression suggests that the Bcl11a−/− HSCs are
constituted of two distinct myeloerythroid-restricted subpopulations. Remarkably, similar myeloid-restricted cells could
also be detected in the wild-type HSC compartment, suggesting selective elimination of lymphoid-competent HSCs after
Bcl11a deletion. These defects are experimentally validated in serial transplantation experiments where Bcl11a−/− HSCs are
myeloerythroid-restricted and defective in self-renewal.
Conclusions: Our study demonstrates the power of single-cell transcriptomics in dissecting cellular process and lineage
heterogeneities in stem cell compartments, and further reveals the molecular and cellular defects in the Bcl11a-deficient
HSC compartment.Background
Continuous and responsive hematopoiesis is essential
for hematopoietic homeostasis throughout the life of
a mammalian individual. The classical model of
hematopoiesis described this process in a developmen-
tal hierarchy, where multipotent hematopoietic stem
cells (HSCs) situate at the apex [1]. Purified HSCs are
able to provide long-term reconstitution to all blood
lineages in transplantation experiments [2–5]. In adult
mice, HSCs reside in the bone marrow and remain* Correspondence: pl2@sanger.ac.uk
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article, unless otherwise stated.predominantly mitotically quiescent. Only a small por-
tion of HSCs are cycling to maintain hematopoietic
homeostasis or in response to stress and injury [6].
Lymphoid and myeloid blood cells are derived from
successive differentiation of respective lineage progeni-
tors with the loss of reconstituting potential upon
commitment. HSCs generate multipotent progenitors,
which in turn give rise to lineage progenitors, i.e., the
common myeloid progenitors (CMPs) and common
lymphoid progenitors (CLP). CLPs subsequently pro-
duce B/T lymphocytes, whereas CMPs further differ-
entiate to megakaryocyte–eryhroid progenitors (MEPs)
and granulocyte–macrophage progenitors (GMPs) to
reconstitute erythrocytes, platelets and myeloid cells.
Transcription regulators play critical roles in the HSC
compartment and direct stem cell differentiation [7, 8].e is distributed under the terms of the Creative Commons Attribution 4.0
ns.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
give appropriate credit to the original author(s) and the source, provide a
indicate if changes were made. The Creative Commons Public Domain
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transcription factor B cell CLL/lymphoma 11A (Bcl11a)
is essential for both fetal and adult lymphoid develop-
ment [9, 10]. Bcl11a is also highly expressed in the adult
HSC compartment, and Bcl11a-deficient HSCs fail to
contribute to CLP development in vivo [9]. Increasing
evidence suggests that the phenotypically defined HSC
compartment is heterogeneous and a portion of HSCs
display lineage bias or restriction [8, 11–15]. It is pos-
sible that the lymphoid defect in Bcl11a-deficient
HSCs is dependent on its functions in the regulation of
lineage-priming heterogeneities in the HSC compart-
ment. However, unbiased transcriptomic dissection of
the HSC compartment at the single-cell level was pre-
viously hampered by the rarity of HSCs. This technical
obstacle has recently been overcome by the advance of
RNA-seq technology [16, 17], which allows genome-
wide transcriptome analysis to be conducted at the
single-cell level.
In this report, we applied a semi-automated microflui-
dic system to dissect the transcriptomic heterogeneities
and reconstruct the cell cycle progression in the Lin−
Sca1+ Kit+ (LSK) CD150+48− and Lin− Sca1+ Kit+ (LSK)
CD150+48−34−135− HSC compartments at the single-
cell level. These exercises further revealed the molecu-
lar and cellular defects in the Bcl11a-deficient HSC
compartment, which only contains myeloerythroid-
restricted progenitor-like cells with substantial self-
renewal defects.
Results
Single-cell transcriptome profiling of adult HSCs using a
microfluidic system
We employed the Fluidigm microfluidic system coupled
with multiplex barcoding to streamline the workflow in
cell sorting and cDNA generation. The use of the micro-
fluidic system allowed us to visually confirm the pres-
ence of single cells in individual capture sites under the
microscope and to filter out debris that may otherwise
be mistaken as single cells in flow cytometry. A maximum
of 96 cells can be captured and cDNA reverse transcription
could be generated in situ in each integrated fluidic circuit.
We analyzed the LSK CD150+48− HSC compartment
(Bcl11a+/+) from eight Bcl11a-GFP reporter conditional
knockout mice that we previously described [9] (Fig. 1a).
An IRES-eGFP cassette was targeted at the 3’ untranslated
region of the Bcl11a locus, which enabled tracking of
Bcl11a expression by green fluorescent protein (GFP). The
reporter mice have normal HSC development and
functions [9]. Additionally, we also purified HSCs
(sBcl11a+/+) with a more stringent sorting scheme
(LSK CD150+48−34−135−) from ten wild-type C57BL/6
mice (Fig. 1a). Notably, the majority (81 %) of the LSK
CD150+48− compartment is also LSK CD150+48−34−135−,in contrast to the progenitor cell compartment (14 % of
LSK CD150−48+), indicating significant overlap between
the sorting schemes. The single-cell capture rate by the
microfluidic integrated fluidic circuit was 86.5 % (83/96)
and 54.2 % (52/96) for Bcl11a+/+ and sBcl11a+/+ HSCs, re-
spectively (Fig. 1b). To investigate the role of Bcl11a in
the HSC compartment, we used Bcl11aflox/flox; ROSA26-
Cre-ERT2 mice to obtain LSK CD150+48− Bcl11a−/−
HSCs (Bcl11a−/−) [9]. Bcl11a deletion was induced by
treating the mice with tamoxifen [9]. One week after
tamoxifen treatment, HSCs were purified using
fluorescence-activated cell sorting (FACS) from five mice
and the single-cell capture rate was 85.4 % (82/96). Cell
lysis, cDNA reverse transcription and pre-amplification by
PCR were performed and harvested by the C1 Single-Cell
Auto Prep system. The sequencing libraries of individual
cells of each experiment group (Bcl11a+/+, sBcl11a+/+ or
Bcl11a−/−) were then pooled separately and sequenced.
After quality control, cells with low numbers of reads
(<500,000 in annotated genes), low numbers of detectable
genes (<3000 annotated genes), high fractions of mito-
chondrially encoded transcripts (>10 %) or anomalies seen
under microscope were filtered out. We also removed
cells showing incomplete Bcl11a exon 4 deletion in the
Bcl11a−/− dataset (Additional file 1). In total, 76 Bcl11a+/+
HSCs, 44 sBcl11a+/+ HSCs and 61 Bcl11a−/− HSCs were
further analyzed. The average number of unique counts of
genes was 3.16 million (range 1.43–4.52 million) per cell
(Bcl11a+/+), 0.89 million (range 0.55–1.71 million) per cell
(sBcl11a+/+) and 3.67 million (range 0.54–12.5 million)
per cell (Bcl11a−/−). Standardized External RNA Controls
Consortium (ERCC) RNA spike-ins were added to the se-
quencing library to account for the technical variability of
the protocol [18]. One significant outlier cell from the
Bcl11a+/+ dataset was removed from downstream analysis
after principal component analysis (PCA; Fig. 1c). The
lower count number from the sBcl11a+/+ dataset is not
unexpected due to the lower sequencing depth
("Methods and materials"), but the numbers of genes
detected (normalized count >1) between two wild-type
datasets after size factor normalization are comparable
(Wilcox rank sum test p = 0.362) (Fig. 1d).
Cell cycle activity represents the dominant source of
transcriptional heterogeneity in the HSC compartment
Single-cell transcriptomic analysis allows the detection
of gene expression variability between individual cells
and identification of cellular subpopulations. Expression
variability of a particular gene could come from tech-
nical sources (e.g., stochasticity of reverse transcription
reaction and library preparation) or genuine biological
sources (e.g., differences in cellular states, distinct bio-
logical subpopulations and transcription kinetics). It is
crucial, therefore, to properly account for the technical
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Fig. 1 Single-cell transcriptome profiling of mouse HSCs by microfluidic system. a Gating strategy for HSC purification. Bcl11a+/+ and Bcl11a−/− HSCs were
isolated by sorting markers LSK CD150+48− and sBcl11a+/+ HSCs by markers LSK CD150+48−34−135−. Lineage markers used for enrichment included B220,
CD19, CD3, CD4, CD8, TCRγδ, TCRβ, NK1.1, CD11b, Gr-1, Ter119. FSC: Forward scatter, SSC: Side scatter. b Single-cell capturing efficiency by the C1 AutoPrep
microfluidic system and representative microscopic images of individual capture sites. A representative high-quality single HSC at an individual capture site
is indicated by the red arrow. Representative pictures of poor quality cells, an empty capture site and a multiplet capture site are framed in colors
as indicated in the key. c Principal component analysis of the transcriptome of all 181 HSCs passed initial computational quality control. One
significant outlier from the Bcl11a+/+ dataset was identified (marked by red arrow). It was removed from subsequent analysis. d Boxplot
comparing the number of genes detected (normalized count >1) in the sBcl11a+/+ and Bcl11a+/+ datasets. The two datasets were comparable,
despite low sequencing depth of the sBcl11a+/+ dataset
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ation. Brennecke et al. [18] recently described a statistical
approach to address this problem by the addition of
standardized external RNA spike-ins to the sequencing
library. The null hypothesis is that the expression vari-
ability detected in a particular gene is not different
from the technical variability measured by the external
RNA spike-ins; thus, genes that display higher than
expected variability imply genuine biological fluctu-
ation from possible cellular subgroups. We identified
6,597, 7,716 and 5503 highly variable genes in the
Bcl11a+/+, sBcl11a+/+ and Bcl11a−/− datasets, respect-
ively (Fig. 2a; Additional file 2). Remarkably, gene
ontology (GO) term enrichment analysis showed that
terms related to cell cycle were significantly over-
represented in all three datasets (p < 0.0001; Fig. 2b;
Additional file 2). This result suggested that cell cycle activ-
ity is the dominant source of transcriptomic heterogeneity
among HSCs.
Transcriptional reconstruction of cell cycle progression in
the HSC compartment
To resolve the cell cycle heterogeneities in the HSC
compartment, we focused on the expression pattern of
cell cycle-associated genes in the merged Bcl11a+/+ HSC
dataset (Bcl11a+/+ and sBcl11a+/+). We compiled a list
of 2212 cell cycle-associated genes based on the annota-
tions in the GO term “cell cycle”, the Cyclebase database
and a recent study on G0/G1 transition by Oki et al.
[19] (Additional file 3). PCA was performed to transform
the high dimensional expression data into individual
linearly uncorrelated principal components. Interest-
ingly, we observed that HSCs displayed a characteristic
distribution pattern in the first two principal compo-
nents (PC1/PC2; Fig. 3a). To aid visualization, we
grouped HSCs into five smaller clusters (C1–5) (Fig. 3a)
based on their proximity in the PCA plot (Fig. 3b). The
grouping is largely consistent with hierarchical clustering
(Fig. 3c). To understand if the distribution of the HSCs
depicted a cell cycle progression trajectory, we inspected
the expression pattern of stage-specific genes based on
their annotations in the Cyclebase database and from lit-
erature [20]. It appeared that genes situated at different
spatial domains of the plot showed clustered expression
of stage-specific genes. For instance, the C1 clusters
showed high expression of the quiescence regulator of
Cdkn1c (p57) and G1 arrest factor Txnip [21, 22] and lack
of the methylation and G1/S entry regulator Uhrf1 [23]
(Fig. 3d). C3 was dominated by S phase-specific genes such
as Rrm2 [24] and DNA replication-licensing factors
(e.g., Mcm2, Mcm5, Mcm7), while the C4 cluster
expressed high levels of genes involved in cell division
(e.g., Prc1, Mki67 (Ki-67)) (Fig. 3d). Correspondence of
individual clusters to specific cell cycle stages is furthersupported by the distinct pattern of cyclin and cyclin-
dependent kinase expression in specific clusters
(Fig. 3d). Cyclins are known to oscillate at specific cell
cycle stages when they form complexes with partnering
cyclin-dependent kinases to drive cell cycle progres-
sion [25]. Cyclin E (Ccne2) regulates G1/S transition
with CDK2 (Cdk2), cyclin A (Ccna2) is specifically active
in S phase, and cyclin B (Ccnb2) functions at G2/M phase
transition with CDK1 (Cdk1). Cyclin F expression closely
followed that of cyclins A and B [26]. Cyclin D (Ccnd2) is
first expressed in G1 phase and involved in G1/S transition,
and its expression is sustained in proliferative cells. The ex-
pression levels of specific cyclin genes therefore provided a
good molecular marker to define the cell cycle stages of dif-
ferent cell clusters. Concordant to the clustering pattern in
PCA, the cyclin expression patterns across clusters C1–4
closely recapitulated the known cyclin oscillation during
cell cycle progression (Fig. 3d). This correlation combined
with the expression patterns of Cdkn1c and Txnip allowed
us to reconstruct a transcriptomically defined cell cycle and
assign the cell cycle stage of C1 (72/119 cells) as G0/early
G1 phase, C2 (14/119) as late G1 phase, C3 (21/119) as S
phase and C4 (10/119) as G2/M phase (Fig. 3b, d). The
status of the C5 clusters is undetermined due to the
low number of cells. Interestingly, the fraction of HSCs
classified as G0/early G1 phase in both the Bcl11a+/+
(28 %, 54/75) and sBcl11a+/+ (27.3 %, 32/44) datasets
are similar, consistent with our finding that the sorting
schemes of LSK CD150+48− and LSK CD150+48−34−135−
are mostly overlapping (Fig. 1a).
We then applied this classification to explore the mo-
lecular differences between the “G0/early G1 phase” C1
and “S phase” C3 clusters. We performed gene set en-
richment analysis (GSEA) on gene sets curated in the
Kyoto Encyclopedia of Genes and Genomes (KEGG)
database. Gene sets related to “cell cycle” and “DNA rep-
lication” are significantly enriched as expected (Fig. 3e).
In addition, we also detected significant enrichment of gene
sets involved in DNA damage repair such as “mismatch
repair” and “nucleotide/base excision repair”. This finding
is in accordance with recent reports that quiescent adult
HSCs accumulate DNA damage and this damage is
repaired upon entry into the cell cycle [27–29]. Similarly,
enrichment of “p53 signaling pathway” is also detected in
the proliferative C3 cluster, consistent with its role in the
orchestration of DNA damage repair [30]. Furthermore,
gene set enrichment of “oxidative phosphorylation” and
“citrate cycle” in the C3 cluster is supported by the observa-
tion that quiescent HSCs undergo a glycolytic to aerobic
metabolic transition upon activation [31]. Interestingly,
gene sets associated with “ubiquitin-mediated proteolysis”
is also significantly enriched, affirming the role of the
ubiquitin proteasome system in the regulation of HSC
cell cycle regulation [32]. These results suggest that
A B
Fig. 2 (See legend on next page.)
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Fig. 2 Identification of cell cycle activity as the dominant source of transcriptional heterogeneities in the HSC compartment. a Identification of
highly variable genes in Bcl11a+/+ (upper panel), sBcl11a+/+ (middle panel) and Bcl11a−/− (lower panel) HSCs. The expression variability of individual
genes measured by the squared coefficient of variation (CV2) is plotted against the mean expression level (normalized counts). Magenta points
indicate mouse genes (Bcl11a+/+, 6597; sBcl11a+/+, 7716; Bcl11a−/−, 5503) showing higher than expected expression variability compared with
external RNA spike-ins (blue) (adjusted p value <0.1). The red line is the fitted line of the spike-ins and the dashed line marks the margin for genes
with 50 % biological CV. b The top 20 gene ontology terms enriched in the highly variable genes among Bcl11a+/+ (upper panel), sBcl11a+/+
(middle panel) and Bcl11a−/− (lower panel) HSCs. The p value was adjusted by the Benjamini and Hochberg method for multiple testing
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RNA-seq data permits direct comparison of the bio-
logical characteristics of HSCs at different cell cycle
stages in silico.
Acute Bcl11a deletion in the HSC compartment alters cell
cycle progression
We next examined the HSC compartment when Bcl11a
was deleted. Notably, the distribution of Bcl11a−/− HSCs
in PCA closely mimicked that of merged Bcl11a+/+
HSCs in terms of cell cycle-related genes (Fig. 4a).
Nevertheless, there were more Bcl11a−/− cells (59.0 %,
36/61 cells) in the space occupied by the proliferative C3
and C4 clusters of the control Bcl11a+/+ HSCs (26.1 %,
31/119) (Fig. 4a), suggesting that Bcl11a deficiency is as-
sociated with increased proliferation in the HSC com-
partment. Moreover, we observed a significant increase
of transcription activity in the proliferating Bcl11a−/−
HSCs compared with controls, estimated by the total
number of ERCC-normalized counts per cell (Fig. 4b).
This is consistent with a previous report that transcrip-
tion rate periodically increases from G1 to S/G2/M
phase [33] and suggests that Bcl11a−/− HSCs are more
transcriptionally active. There was also evident general
up-regulation of cyclin genes and down-regulation of the
quiescence regulator Cdkn1c (p57) and G2/M markers
such as Prc1, Plk1 and Mki67 (Ki-67) [20] (Fig. 4c). Not-
ably, genes encoding HSC activation and progenitor
markers such as Cd34 and Cd244 were also elevated
[34, 35]. Moreover, examination of the gene expression
correlation of transcription factors revealed that there
were two anti-correlative gene clusters (Fig. 4d, cluster
I in red and II in blue) in the HSC compartment. Clus-
ter I genes were enriched for GO cell cycle terms like
“interphase”, suggesting their actions in cell cycle regu-
lation (Fig. 4e). Meanwhile, the expression of Bcl11a in
cluster II correlated with multiple known HSC quiescence
regulators such as Egr1[36], Fos [37], Mecom [38], Meis1
[39], Hlf [40], and Nr4a1 [41] (Fig. 4d). Signaling mediators
important for HSC quiescence, such as Notch signaling
(Hes1) [42], Wnt signaling (Tcf7l2) [42] and TGFβ signaling
(Id1 and Id3) [43] can also be found in cluster II. These
suggest that Bcl11a may cooperate with these regulators in
maintaining HSC quiescence. To confirm the prediction
that Bcl11a−/− HSCs have reduced quiescence, weperformed in vivo 5-bromodeoxyuridine (BrdU) staining
for cell cycle profiling. As predicted, significantly
higher numbers of BrdU+ cells were found in either the
Bcl11a+/− or Bcl11a−/− HSC compartment compared
with the control (Fig. 4f, g). Furthermore, Bcl11a−/− HSC
compartment had significantly more proliferative cells com-
pared with haploinsufficient Bcl11a+/− HSCs, indicating a
dose-dependent requirement for Bcl11a. These tran-
scriptomic and experimental results demonstrate a cell
cycle defect in the Bcl11a−/− HSC compartment.Bcl11a-deficient HSCs have defects in long-term self-
renewal potential
The cell cycle defect in Bcl11a-deficient HSCs prompted
us to examine their self-renewal potential. We first ex-
amined the expression of the self-renewal gene signature
by GSEA. We retrieved the signature gene set described
by Krivtsov et al. [44] as associated with HSC and
leukemic stem cell self-renewal (Additional file 3). We
detected a highly significant reduction of expression in
Bcl11a−/− HSCs (Fig. 5a). To experimentally test this
observation, we transplanted purified Bcl11a−/− or
Bcl11a+/− LSKs (CD45.1−) to sublethally irradiated
CD45.1+ recipient mice. Donor contribution in the
peripheral blood was examined at different time points
after the adoptive transfer. Bcl11a−/− LSKs had sub-
stantially lower capacity to generate hematopoietic
progenies, and contributed much less efficiently in the re-
cipients than the Bcl11a+/− LSKs (Fig. 5b). Furthermore,
the secondary recipient mice had drastically decreased
Bcl11a−/− HSCs, both percentage-wise and total cell num-
bers (Fig. 5c, d), which was further confirmed by using an
alternative HSC sorting scheme (LSK CD34−135−) (Fig. 5d).Bcl11a deletion eliminated lymphoid-competent HSCs and
resulted in expansion of two myeloerythroid-restricted
subpopulations in the HSC compartment
We have previously demonstrated experimentally that
Bcl11a is essential in the generation of lymphoid progeni-
tors, including lymphoid-primed multipotent progenitors
and CLPs, but its effects on HSCs at the single-cell level
were unclear [9]. We thus attempted to interrogate the ef-
fect of Bcl11a deficiency on the lineage multipotency of
HSCs with our single-cell transcriptomic dataset.
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Fig. 3 Transcriptomic reconstruction of cell cycle progression by single-cell RNA-seq. a PCA of Bcl11a+/+ HSCs based on the expression of 2212
cell cycle-related genes annotated in the GO, Cyclebase database and Oki et al. [19]. The loading plot of the first two principal components is
shown. Each point represents one HSC. b Subgrouping of Bcl11a+/+ HSCs by PCA. The Bcl11a+/+ HSCs were grouped into five different clusters
(C1–5) based on their proximity in the PCA loading plot as in (a). c Hierarchical clustering and Pearson correlation heatmap of Bcl11a+/+ HSCs.
Correlation between Bcl11a+/+ HSCs was estimated by the Pearson correlation coefficients. The column and row colors shown above and to the
left correspond to the five subgroups by PCA as in (b). d PCA loading plots of Bcl11a+/+ HSCs as in (a) with expression of selected cell cycle
stage-specific genes overlaid. The expression level was calculated as log10 (normalized counts +1). e The normalized enrichment scores of significantly
enriched gene sets (p < 0.05, false discovery rate < 0.05) in the C3 cluster compared with the C1 cluster curated by the Kyoto Encyclopedia of Genes and
Genomes (KEGG) database. GSEA gene set enrichment analysis
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“hematopoiesis and lymphoid organ development” in the
GO database and the literature (Additional file 3) and
studied their expression in HSCs with PCA. Annotated
hematopoietic genes also involved in cell cycle activity
were removed from the compilation to reduce their effect
on heterogeneity dissection. Notably, significant overlap of
Bcl11a+/+ and sBcl11a+/+ HSCs can be observed in the
PCA (Fig. 6a, upper panel). The Bcl11a−/− HSCs are segre-
gated into two uneven subpopulations, with the larger sub-
population partially overlapping the merged Bcl11a+/+
(Bcl11a+/+ and sBcl11a+/+) HSCs. The smaller and more
scattered Bcl11a−/− HSC subpopulation clusters with few
sBcl11a+/+ HSCs at the right lower quadrant of the loading
plot of the first two principal components (Fig. 6a,
upper panel).
To aid visualization and downstream comparison, we
again grouped the HSCs shown in Fig. 6a into four sub-
groups (H1–4) based on their locations on the loading
plot (Fig. 6a, middle panel). Intriguingly, the expression
pattern of hematopoietic genes pointed to a clustered
expression of markers associated with specific lineages
(Fig. 6b). For instance, expression of mega-erythroid
genes such as Epor, Selp, Gp9, and Gfi1b [45, 46] were
clustered in subgroups H2 and H3, while myelopoietic
genes such as Mpo, Cebpa [47], Gfi1 [48], and Csf1r
were concentrated at the H4 subgroup. Interestingly, the
known antagonistic regulation between Gfi1 and Gfi1b is
recapitulated by the reciprocal exclusion of the two reg-
ulators in the H3 and H4 subgroups [49, 50]. Compared
with the H1 subgroup, the H3 and H4 subgroups showed
reduced expression of lymphoid and HSC activation regula-
tors such as Egr1, Bcl11a, and Jun, but prevalent expression
of progenitor markers like Cd34 and Cd48 (Fig. 6b).
Overlaying the cell cycle staging information on the PCA
plot of hematopoietic lineage genes (Fig. 6a, lower panel),
we found that most of the cells in the H1 subgroup belong
to the C1 (G0/early G1 phase) and C2 (late G1 phase) clus-
ters. Wild-type HSCs which clustered with Bcl11a−/− HSCs
in the H4 subgroup belong to either C3 (S phase) or C4
(G2/M phase) (Fig. 6a, lower panel).
We then performed GSEA to further compare lineage
progenitor signature enrichment between the different
subgroups (Fig. 6c, d). The signature gene sets wereretrieved from Sanjuan-Pla et al. [13] (Additional file 3)
and comparison between Bcl11a+/+ and Bcl11a−/− HSCs
showed an expected depletion of the lymphoid signature,
consistent with our previous report [9] (Fig. 6c). In
addition, the H1 subgroup is enriched with the lymphoid
and self-renewal signature, while the H3 and H4 sub-
groups are enriched with the erythroid and granulocyte-
macrophage signatures, respectively (Fig. 6d). Further
HSC transplantation experiments also confirmed that
Bcl11a−/− HSCs, which dominated the H3 and H4
subgroups, are myeloid-restricted, and that the myeloid
progenitor compartments (CMPs, GMPs and MEPs)
were not affected in both acute Bcl11a deletion mice
and primary recipients after Bcl11a deletion (Fig. 6e–h).
Collectively, a trajectory of gradual loss of lymphoid
and self-renewal potential can be discerned as wild-type
HSCs become activated and proliferative when transiting
from the lymphoid-competent H1 subgroup to the mega-
erythroid-restricted H3 subgroup or the granulocyte-
macrophage-restricted progenitor-like H4 subgroup. More
importantly, the existence of sBcl11a+/+ HSCs in the H4
subgroup suggest that myeloid-restricted cells similar to
Bcl11a−/− HSCs have already existed in the wild-type HSC
compartment. The Bcl11a−/− HSCs likely come from
expansion or activation of existing myeloid-restricted HSCs
in the wild-type compartment after the elimination of
lymphoid-competent HSCs by Bcl11a deletion.
Discussion
The hematopoietic system has been an area of intense
research because of its paramount clinical potential. The
discovery of specific surface markers for purification of
HSCs in the adult mouse model allowed us to study the
key biological properties of self-renewal and lineage
commitment. Recently, increasing evidence from clonal
transplantation assays supports the phenotypically defined
HSC compartment as being functionally heterogeneous,
with subpopulations of platelet-primed or myeloid-
restricted HSCs [13, 14]. In this study, we have profiled
the transcriptomes of 180 HSCs in the mouse adult
HSC compartment and studied the transcriptome
structure and the role of Bcl11a in the HSC compart-
ment. We show that single-cell transcriptomics could
be used to reconstruct biological processes, dissect
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Fig. 4 Bcl11a-deficient HSCs showed significant proliferative changes in the HSC compartment. a Distribution of Bcl11a−/− HSCs (purple) and cell
cycle reconstructed-Bcl11a+/+ HSC clusters (C1–C5) in a PCA loading plot of the first two principal components. b Boxplots comparing the
transcriptional activity of G0/G1 stage (C1 and C2) and S/G2/M stage (C3 and C4) HSCs in the Bcl11a+/+ and Bcl11a−/− datasets, estimated by the
total number of read counts normalized by ERCC size factor per cell. c Violin plots of gene expression of selected cyclin genes, progenitor
markers and cell cycle stage-associated genes in Bcl11a+/+ and Bcl11a−/− HSCs. The black dots represent the mean expression for each gene.
d Heatmap showing expression correlations of selected transcription regulators in the HSC compartment. Correlation coefficient was calculated
by Spearman correlation coefficient and clustering was performed by complete linkage. Gene correlation cluster II (blue) is magnified. e Enriched
GO terms in gene correlation cluster I [red in (d)]. f Validation of cell cycle changes in Bcl11a−/− HSCs by 5-bromodeoxyuridine (BrdU) staining.
The purple box marks the BrdU+ fraction in the HSC compartment of different genotypes. FSC-A: Forward scatter area. g The dose-dependent
changes in BrdU+ cell number in the HSC compartment in different Bcl11a genotypes. HSCs were harvested and sorted from adult mouse bone
marrow 5 days after tamoxifen-induced Bcl11a ablation. *p < 0.05, **p < 0.01, n = 3 mice for each group. Bcl11a+/−, CreERT2; Bcl11a+/flox
(treated with tamoxifen); Bcl11a−/−, CreERT2; Bcl11aflox/flox (treated with tamoxifen). The error bar represented mean ± 1 standard deviation
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predict stem cell behavior, such as self-renewal cap-
acity and differentiation potential in silico.
Reconstruction of cell cycle progression at the single-
cell level provides a new avenue to study the molecular
characteristics of quiescent and proliferative HSCs with-
out additional staining or sorting. This advantage is illus-
trated by our demonstration of the direct comparison of
quiescent and proliferative HSCs defined in the recon-
struction by GSEA. Reported features of proliferative
HSCs, such as activation of the DNA damage repair
pathway and transition to oxidative metabolism, can be
clearly identified from such an exercise.We noted that
the fraction of proliferative cells classified by the tran-
scriptomic approach is higher than the estimation by
conventional BrdU staining in this study (~27 % versus
12 %). Others have reported an even lower fraction (<2 %)
of cycling cells with alternative DNA content staining and
Ki67 expression [35]. The discrepancy is not, in fact, unex-
pected; instead, the transcriptomic approach may provide a
more sensitive staging as cell cycle progression requires fur-
ther translational and post-translational regulation. Changes
in the transcriptome are therefore one of the earliest events
in entry to the cell cycle. We further extended the use of
the reconstruction in predicting cell cycle phenotype in the
Bcl11a−/− HSC compartment. Comparison of Bcl11a−/−
and the control datasets predicted reduction of quiescence
in the Bcl11a−/− HSC compartment, which was experimen-
tally confirmed by BrdU staining. Gene expression correl-
ation analysis revealed a correlative expression pattern of
Bcl11a with multiple known quiescence regulators and sig-
naling mediators. The analysis provided a basis for future
mechanistic dissection of Bcll1a in the regulation of HSC
self-renewal and quiescence.
We have previously shown that Bcl11a−/− HSCs are
deficient in lymphoid reconstitution [9]. This defect
could be caused by blockage of lymphoid commitment
at the HSC level or selective elimination of lymphoid-
competent HSCs. The possibility to dissect subpopula-
tions using single-cell RNA-seq data provides a new
avenue to test these hypotheses.Segregation of HSCs on the basis of hematopoietic
gene expression by PCA revealed an interesting separ-
ation of Bcl11a−/− and Bcl11a+/+ HSC expression pat-
terns with partial overlap (Fig. 6a, upper panel). To
better dissect their hematopoietic characteristics, we
subdivided all the HSCs sequenced in this study into
four groups (H1–4) based on their location proximity.
The H1 subgroup overwhelmingly consisted of Bcl11a+/+
HSCs. GSEA of the lineage signature showed that they are
enriched with the self-renewal signature and lymphoid po-
tential. Overlaying the PCA plot with cell cycle stage in-
formation, we found that the lymphoid-competent H1
HSCs contained all the G0/G1 Bcl11a+/+ HSCs (Fig. 6a,
lower panel). In contrast, the H2 subgroups contained
both Bcl11a−/− and Bcl11a+/+ HSCs and the Bcl11a+/+
HSCs in H2 are predominantly proliferative. Few pro-
liferative Bcl11a+/+ HSCs are also present in the H4
subgroup clustering with Bcl11a−/− HSCs. Compared
with the H1 lymphoid-competent subgroup, the H3
and H4 subgroups showed marked enrichment of MEP
and GMP progenitor signatures (Fig. 6d) and high ex-
pression of activation markers such as Cd48 and Cd34.
The computational exercises and experimental data indi-
cate that, firstly, the lymphoid-competent H1 subgroup is
selectively depleted after Bcl11a deletion. Secondly, the
dominance of G0/G1 phase HSCs and the self-renewal
signature in the H1 subgroup compared with the H2 sub-
group is associated with lymphoid competency and HSC
self-renewal. Thirdly, the presence of mixed myeloid-
restricted Bcl11a−/− and Bcl11a+/+ HSCs in the H2 and H4
subgroups suggests the pre-existence of myeloid-restricted
Bcl11a−/−-like HSCs in the wild-type compartment.
Fourthly, the clear MEP- and GMP-like signature distinc-
tion in the H3 and H4 subgroups suggests that the
myeloerythroid-restricted Bcl11a−/− HSC compartment is
constituted of two distinct progenitor-like subpopulations.
Finally, the close relationship of the H3 and H4 subgroups
with the H2 subgroup suggests that they may arise from ac-
tivation and expansion of the latter subpopulations after
Bcl11a deletion. Based on this evidence, we propose that
Bcl11a serves two roles in the HSC compartment: in the
AD
B C
Fig. 5 Bcl11a-deficient HSCs show self-renewal defects. a Gene set enrichment analysis showing significant depletion of the self-renewal gene
signature in Bcl11a−/− HSCs (p < 0.001). The normalized enrichment score (NES) of 1.64 indicates significantly higher self-renewal gene expression
in the Bcl11a+/+ HSCs compared with Bcl11a−/− HSCs. b Percentage of donor cells in total nucleated peripheral blood (PBL) cells along with time
after transfer. We injected 2000 Bcl11a+/− or Bcl11a−/− LSKs (CD45.1−) with 1.0 × 106 bone marrow (BM) cells (CD45.1+) into sublethally irradiated
recipient mice (CD45.1+). c Comparison of the number of donor LSK cells and HSCs in secondary recipient mice 18 weeks post-secondary transfer;
*p < 0.05, **p < 0.01. d FACS dot plot of donor Bcl11a+/− and Bcl11a−/− HSCs (LSK CD150+48− and LSK CD34−135(Flt3)−) in secondary recipient
mice. BM cells were analyzed 18 weeks post-secondary transfer. Bcl11a+/−, CreERT2; Bcl11a+/flox (treated with tamoxifen); Bcl11a−/−, CreERT2;
Bcl11aflox/flox (treated with tamoxifen). In panels (b) and (c), at least three mice were used for each time point or each cell type in independent
experiments. The error bar represented mean ± 1 standard deviation
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regulation of HSC self-renewal. Deletion of Bcl11a select-
ively eliminated lymphoid-competent HSCs, causing the
lymphoid deficiency in the Bcl11a−/− compartment. The
myeloerythroid restrictive phenotype of Bcl11a−/− HSCs is
contributed by the residual surviving myelo-restricted sub-
populations in the HSC compartment, which may have lim-
ited self-renewal potential.
The detection of Bcl11a−/−-like wild-type HSCs (H2 and
H4 subgroups) in the wild-type compartment in our datasetraises interesting questions about their resemblance to
the recently reported myeloid-restricted repopulating
progenitors in the myeloid bypass model proposed by
Yamamoto et al. [14]. In that study, HSCs were purified
with a variant sorting scheme (LSK CD150+34−41+), which
selectively enriched myeloid-biased HSCs [5, 11, 12, 14].
Notably, Itga2b (CD41) was also found to be expressed pre-
dominantly in the H2 and H3 clusters in our dataset,
supporting the mega-erythroid signature enrichment in
these cells (Fig. 6b). Nonetheless, we did not observe
AE
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Fig. 6 (See legend on next page.)
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Fig. 6 The Bcl11a-deficient HSC compartment contained two distinct myeloerythroid subpopulations and showed myeloerythroid-restriction in
lineage reconstitution. a PCA loading plot of HSCs based on their expression of hematopoietic genes. Upper panel: the HSCs were labeled based
on their corresponding genotypes. Middle panel: HSCs were grouped into four different subgroups and colored based on their locations in the
loading plot. Lower panel: HSCs were labeled based on their cell cycle stages defined in Fig. 3b. b PCA loading plot of HSCs with expression of
selected hematopoietic genes overlaid. The expression level is calculated as log10(Normalized counts + 1). c GSEA showing significant depletion
of the common lymphoid progenitor signature in Bcl11a−/− HSCs (p < 0.001). The normalized enrichment score (NES) of 1.61 indicates significantly
higher lymphoid signature in the Bcl11a+/+ HSCs compared with Bcl11a−/− HSCs. d Normalized enrichment scores of different lineage progenitor
signatures in different subgroup pair-wise comparisons. *: p <0.05, **: p <0.01 e Analysis of the number of bone marrow (BM) CMPs, GMPs and
MEPs with different genotypes by flow cytometry one week after tamoxifen injection. Numbers refer to percentages in total BM nucleated cells.
Lin− BM cells were analyzed and n = 4 mice for each genotype. f Comparison of the numbers of myeloerythroid progenitors with different
genotypes as in (e). g Analysis of the number of BM CMPs, GMPs and MEPs in primary recipient by flow cytometry 8 weeks after LSK and helper
BM cells transplantation from donors (CD45.1−) with different genotypes. Numbers refer to percentages of progenitors in total BM nucleated cells.
h Comparison of the cell numbers of myeloerythroid progenitors in different genotypes as in (g). Cells were harvested from the two femurs of
each mouse (n = 4/genotype). The error bar represented mean ± 1 standard deviation
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suggested to mark platelet-primed primitive HSCs in
mice [13]. The transcriptomic relationship of these
variant HSC compartments with the Bcl11a−/− HSCs
thus warrants further investigation.
Conclusions
We have successfully applied single-cell transcriptomic
analysis in reconstructing the cell cycle process and dis-
secting the molecular heterogeneities of the rare HSC
population. Our data reveal the diversity of lineage-
biased subpopulations and the effect of Bcl11a in the
maintenance of the HSC compartment. Bcl11a is essen-
tial in the maintenance of lymphoid-competent HSC
survival and self-renewal.
Materials and methods
Mice
Bcl11aflox/floxRosa26CreERT2/CreERT2 and Bcl11aeGFP/eGFP
mice were previously reported [9]. F1 hybrid wild-type
mice from C57BL/6 CD45.1+ crossed with 129S5 mice
were used as recipients for transplantation of bone mar-
row or LSK cells. All mice used were from colonies main-
tained at the Research Support Facility of the Wellcome
Trust Sanger Institute. Housing and breeding of mice and
experimental procedures were according to the UK
1986 Animals Scientific Procedure Act and the Animal
Welfare and Ethical Review Body of the Wellcome
Trust Sanger Institute.
Flow cytometry
Single-cell suspensions were incubated with purified
anti-CD16/32 (clone 93) for 10 min on ice to block Fc
receptors. Fluorochrome- or biotin-labeled monoclonal
antibodies (clones denoted in parentheses) against B220
(RA3-6B2), CD19 (1D3), CD3ɛ (145-2C11), CD4 (RM4-5),
CD8 α (53–6.7), TCRβ (B20.6), NK1.1 (PK136), CD11b
(M1/70), Gr1 (RB6-8C5), Ter119 (TER-119), Sca1 (D7),
c-kit (2B8), CD48 (HM48-1), CD150 (TC15-12 F 12.2),CD34 (RAM34), and Flt3 (A2F10) were purchased from
BD Biosciences, BioLegend or eBioscience. Cells were
stained with antibodies on ice for 20 min before washing.
Cells were run on a Fortessa (BD Biosciences) or MoFlo
XDP (BD Biosciences) and analyzed by Flowjo (Tree Star).
For HSC sorting, Lin− cells were enriched by Lineage Cell
Depletion Kit (Miltenyi Biotec) before antibody staining.
Cell-cycle analysis
Mice were given a single intraperitoneal injection of
(BrdU (100 μg g−1 mouse weight) and then maintained
on 0.8 mg/ml BrdU in the drinking water for 14 or 20 h
before being euthanized. HSCs were double FACS-sorted
from mouse bone marrow. BrdU incorporation was
measured by flow cytometry using an APC BrdU Flow
Kit (BD Pharmingen) according to the manufacturer’s
instructions.
In vivo transplantation assay
Transplantation assays were performed using the
CD45.1/CD45.2 congenic mouse system. The total
nucleated bone marrow cells or LSK cells were purified
from bone marrow of the flox/flox mice and the control
mice (+/flox) treated with tamoxifen for 4–5 days. The
bone marrow cells (1–5 × 105) or sorted LSK cells (2000
cells) were injected with helper CD45.1+ bone marrow
cells (2 × 105 cells) into lethally irradiated (2 × 500 cGy)
recipient mice (CD45.1+) via the tail vein. For the sec-
ond bone marrow transplantation, bone marrow cells
(0.2–1 × 106) were obtained from recipient mice 16
weeks after first transplantation, and transplanted into
a second set of lethally irradiated (2 × 500 cGy)
CD45.1+ recipient mice.
Single-cell RNA-seq library preparation
Two thousands FACS-sorted Bcl11a+/+ and Bcl11a−/−
HSCs pooled from eight and five mice, respectively, were
loaded onto two separate 5–10 μm C1 Single-Cell Auto
Prep integrated fluidic circuits (Fluidigm) and cell
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protocol. Similarly, 1000 sBcl11a+/+ HSCs from 10 mice
were loaded. Individual capture sites were inspected
under light microscope to confirm the presence of single
cells. The locations of empty capture sites and sites con-
taining multiple cells or burst cells were noted for down-
stream quality control during data analysis. The lysis
and reverse transcription mixes were then prepared with
the SMARTer PCR cDNA Synthesis kit (Clontech) and
the Advantage 2 PCR kit (Clontech) according to Fluidigm
recommendations. The ERCC Spike-In Control Mix (1.0 μl
in a 1:1000 dilution; Ambion) was added to the lysis mix to
allow control of technical variation of the library prepar-
ation protocol. Lysis and cDNA reverse transcription and
PCR were performed and cDNA harvested by the C1
Single-Cell Auto Prep system according to the manufac-
turer’s settings. The success of cDNA preparation was
confirmed by optimal DNA signal detected by a 2100
Bioanalyzer with High-sensitivity DNA chip (Agilent).
Multiplex sequencing libraries were then prepared
using the Nextera DNA Sample Preparation Kit and
the Nextera Index Kit (Illumina) according to the rec-
ommendation in the C1 Single-Cell Auto Prep manual.
The libraries of individual cells of each experiment
group (Bcl11a+/+/Bcl11a−/−) were then pooled and se-
quenced on four lanes of a HiSeq 2500 (Illumina) to
generate 100-bp paired-end reads through the Wellcome
Trust Sanger Institute in-house sequencing pipeline. For
the sBcl11a+/+ HSC library, samples from empty capture
sites, abnormal cells or multiplets detected by microscopy
were removed before library construction and were simi-
larly sequenced on two lanes of a HiSeq 2500 (Illumina).
The raw sequencing data can be found in the European
Nucleotide Archive (sudy ERP010829).
Read alignment and quality control of dataset
Paired-end reads were aligned to the Mus musculus
genome (Ensembl GRCm38.75 assembly) by GSNAP
(version 2013-08-14) with the following parameter set-
tings: ‘gsnap -A sam -B 5 -t 8 -n 1 -Q –nofails’ [51].
The quantification of expression was performed by the
htseq-count module from the HTSeq package [52]
with gene annotation from GTF files (Ensembl
GRCm38.75 assembly) with parameter “–s no” in
intersection-nonempty mode [53]. Cells with less than
500,000 counts in annotated features, expression of
less than 3000 genes or a high percentage (>10 %) of
counts mapping to mitochondrial genes were removed
from subsequent analysis. Cells with reads detected on
the Bcl11a locus chr11:24163146–24165166 were re-
moved from the Bcl11a−/− dataset as they represent in-
complete exon 4 deletion after tamoxifen induction.
Significant outliers in PCA based on the whole tran-
scriptome were removed from the merged dataset ofBcl11a+/+, sBcl11a+/+ and Bcl11a−/− HSCs (Fig. 1d).
Cells with anomalies, empty capture sites, or multiple
cells at capture sites were removed prior to sequencing
in the sBcl11a+/+ dataset. The quality control summary
is detailed in Additional file 1.
Detection of highly variable genes and statistical analysis
The details of the statistical model for testing highly
variable genes have been described by Brennecke et al.
[18]. We set the minimal biological dispersion parameter
at 0.5. PCA was performed with function prcomp() in
the stats package of R (version 3.0.2 — “Frisbee Sailing”)
based on log2 transformed count matrix by log2(n + 1).
GO enrichment analysis
GO term enrichment analysis was performed by DAVID
Bioinformatics Resources 6.7 [54] with the default mouse
genome as background [55].
Gene set enrichment analysis
GSEA was performed with the javaGSEA application
(version 2.0.14) available online [56] with default settings
[57]. The lineage-specific gene sets (MkP, PreCFU-E,
PreGM, PreMEGE, CLP) were retrieved from a previ-
ously published dataset by Sanjuan-Pla et al. [13]. The
self-renewal signature gene set was retrieved from
Krivtsov et al. [44]. The gene identifiers were remapped
by BioMart [58] to official Ensembl gene symbols. A
normalized count matrix from DESeq2 was supplied as the
input expression dataset. Enrichment is considered signifi-
cant if the false discovery rate is below 0.1 and the nominal
p value is below 0.05.
Statistical analysis
Experimental data are shown as mean and standard
deviation. All statistical analyses were either conducted
with Prism (GraphPad) or as specified in relevant sections.
Additional files
Additional file 1: Table S1. Quality control summary of the Bcl11a+/+,
sBcl11a+/+ and Bcl11a−/− HSC dataset. (XLSX 64 kb)
Additional file 2: Table S2. The list of highly variable genes in the
Bcl11a+/+, sBcl11a+/+ and Bcl11a−/− HSC dataset and the gene ontology
term (biological processes) enrichment analysis results. (XLSX 3257 kb)
Additional file 3: Table S3. The list of annotated cell cycle genes and
hematopoietic regulators used for PCA and the gene sets used for GSEA
in this study. (XLSX 126 kb)
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